UK vets have welcomed news Canadian scientists are testing a prototype vaccine against the virulent porcine epidemic diarrhoea virus (PEDv).

Pig and piglets
The main threat of PEDv is to young pigs, especially those in herds not previously exposed to the virus.

The virus has killed more than eight million animals in the North American swine industry over the last three years, with costs in excess of US$400 million (£600 million).

Occurring only in pigs, PEDv is a coronavirus, a virus group that includes important emerging human diseases, such as severe acute respiratory syndrome. In affected herds it has caused 100% morbidity and 50-100% mortality in suckling piglets.

Although the UK has been PEDv-free for the past 14 years, the danger is the domestic swine herd is naïve to all forms of the virus.

Up to 100% effective

Using its containment level three facility, scientists at the University of Saskatchewan Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) have developed and tested the vaccine.

VIDO-InterVac research director Volker Gerdts said: “Our new facility provided us with the containment infrastructure to develop a vaccine and demonstrate it protected up to 100% of the piglets.”

With the support of the swine industry, the vaccine is undergoing field testing in Saskatchewan, as well as in Manitoba, where it is used to help protect piglets from a PEDv outbreak.

Naïve population

Welcoming the development of a vaccine, a spokesman for the UK’s Pig Veterinary Society said: “PEDv has not been recorded in the UK since 2002 and, consequently, the pig population is believed to be largely naïve to all strains of PEDv. PEDv was made a notifiable disease in England and Scotland in response to industry desire for prompt detection of disease and information on its locations, to allow targeted measures to control disease spread, should it emerge.

“This information about a potential vaccine is welcome news; however, VIDO-InterVac has stressed this is a prototype still undergoing clinical trials at this stage.”

Vaccines against PEDv exist from Zoetis and Harrisvaccines, but some experts have expressed concerns the disease may be mutating, leading to increased global efforts to discover the next generation of medicines.

  • For more details and what to do if disease is suspected, visit http://bit.ly/1fmrL14
  • Read the full article in the 12 September edition of Veterinary Times.
View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz

related content

Ceva Santé Animale has gained a diversified portfolio of products from Boehringer Ingelheim following its acquisition of Merial Animal Health.

2 mins

Two vets are going the extra mile – and then some – in aid of animal welfare by running 10 marathons in 10 consecutive days.

4 mins

Study establishes gun dog breeds, such as retrievers, are straining their locomotor systems by carrying shot game back to their owners.

3 mins

The programme for the 2017 VET Festival has been announced, with more than 100 CPD lectures across 10 streams presented by international speakers.

6 mins

Boehringer Ingelheim Animal Health is celebrating after selling four billion doses of vaccines against Mycoplasma hyopneumoniae, porcine circovirus disease and porcine reproductive and respiratory syndrome.

3 mins

The benefits of pet ownership on human health may help the NHS reduce costs by nearly £2.45 billion – and vets should be praised for playing their part by keeping the nation’s animals healthy, according to a report.

5 mins